Explore 3 Stock Ideas & Industry Insights Download Free Report

News

What Should Investors Expect When Antalpha Platform Holding (NASDAQ:ANTA) Reports Q3 2026 Results on November 16, 2026?

Key Highlights12.2 million USD is theRevenueAntalpha PlatformHolding Company(NASDAQ:ANTA) reported for the second quarter of 2026, down 28% from a year earlier, led by USD 7.7 million of technology financing fees.10 million to USD 12 million is the revenue range management guided for the third …

Vinay Lochav | 13 November 2026

What Should Investors Expect When GameSquare Holdings, Inc. (NASDAQ:GAME) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for GameSquare Holdings, Inc. (NASDAQ:GAME)

Vinay Lochav | 13 November 2026

What Should Investors Expect When 374Water Inc. (NASDAQ:SCWO) Reports Q3 2026 Results on November 16, 2026?

Second quarterGross Profitwas USD 1.98 million, an 87% margin, compared with a gross deficit of about USD 0.3 million, or about -46%, in the second quarter of 2025. Operating expenses fell to USD 3.6 million from USD 4.3 million, and management cited annualized operating …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Xtant Medical Holdings (NYSEAMERICAN:XTNT) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT)

Vinay Lochav | 13 November 2026

What Should Investors Expect When Phunware, Inc. (NASDAQ:PHUN) Reports Q3 2026 Results on November 16, 2026?

Second quarter gross profit was USD 551 thousand at a 69.0% margin, versus USD 190 thousand and 41.8% a year earlier. The operating loss was USD 6.0 million versus USD 4.3 million, the net loss was USD 5.2 million versus USD 3.1 million, and …

Vinay Lochav | 13 November 2026

What Should Investors Expect When OS Therapies (NYSEAMERICAN:OSTX) Reports Q3 2026 Results on November 16, 2026?

In the second quarter of 2026 management reported that 2.5-year overall survival was 75% versus 47%, and that the European Medicines Agency and Australia'sTherapeutic Goods Administrationaligned on 3-year overall survival and biomarker data as approvable measures. Phase 3 design alignment was reached among the …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Rapid Micro Biosystems (NASDAQ:RPID) Reports Q3 2026 Results on November 16, 2026?

Second quarter gross margin was USD 1.2 million, or 15.0%, versus 3.8% a year earlier, while operating expenses rose 8.9% to USD 13.5 million. Adjusted EBITDA loss was USD 10.3 million versus USD 10.1 million. The company placed 4 Growth Direct systems and completed …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Aardvark Therapeutics (NASDAQ:AARD) Reports Q3 2026 Results on November 16, 2026?

The quarter was shaped by regulatory events involving ARD-101, the company's lead candidate for Prader-Willi syndrome. In May 2026 the FDA placed a full clinical hold on the ARD-101 IND following a voluntary pause, and in June 2026 the company terminated the HERO Phase …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Workhorse Group (NASDAQ:WKHS) Reports Q3 2026 Results on November 12, 2026?

Operating expenses were USD 11.9 million in the second quarter, comprising SG&A of USD 7.8 million and R&D of USD 4.1 million. First-half sales were USD 7.9 million versus pro forma USD 8.2 million, and the first-half net loss was USD 40.1 million, or …

Vinay Lochav | 13 November 2026

What Should Investors Expect When NextBoat (NYSEAMERICAN:NXB) Reports Q3 2026 Results on November 16, 2026?

Second quarter operating expenses rose to USD 10.57 million from USD 3.65 million, led by salaries and wages of USD 6.48 million, SG&A of USD 1.44 million and professional services of USD 1.42 million. Interest expense, net, was USD 1.20 million. Management attributed the …

Vinay Lochav | 13 November 2026
Support

Hi! How can we help you today?

Loading…